Cardiac 123I-MIBG uptake is reduced more markedly in patients with REM sleep behavior disorder than in those with early stage Parkinson's disease

Parkinsonism and Related Disorders

Volumn 16, Issue 4, 2010, Pages 252-255

  Kashihara, Kenichi ^a   Imamura, Takaki ^a   Shinya, Takayoshi ^a  

^a OKAYAMA KYOKUTO HOSPITAL   (Japan)

Author keywords

Cardiac MIBG scintigraphy; Cognitive function; MMSE; Orthostatic hypotension; Parkinson's disease; RBD; REM sleep behavior disorder

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; (3 IODOBENZYL)GUANIDINE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

AGED; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE DURATION; DRUG UPTAKE; FEMALE; HEART; HEART SCINTISCANNING; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; ORTHOSTATIC HYPOTENSION; PARASOMNIA; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; CARDIAC GATED IMAGING; PATHOPHYSIOLOGY; SCINTISCANNING;

3-IODOBENZYLGUANIDINE; AGED; FEMALE; GATED BLOOD-POOL IMAGING; HUMANS; MALE; PARKINSON DISEASE; RADIOPHARMACEUTICALS; REM SLEEP BEHAVIOR DISORDER;

EID: 77952884581     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2009.12.010     Document Type: Article

References (29)

1. 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder. Neurology 2006, 67:2236-2238.
2. 123I-MIBG uptake in a patient with idiopathic rapid eye movement sleep behavior disorder. Mov Disord 2007, 22:150-151.
3. 123I-MIBG uptake and impaired facial expression recognition in a patient with REM sleep behavior disorder. Mov Disord 2007, 22:746-747.
4. Postuma R.B., Lang A.E., Massicotte-Marquez J., Montplaisir J. Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology 2006, 66:845-851.
5. Schenck C.H., Bundlie S.R., Mahowald M.W. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder. Neurology 1996, 46:388-393.
6. 123I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiatry 1999, 67:189-194.
7. Takatsu H., Nishida H., Matsuo H., Watanabe S., Nagashima K., Wada H., et al. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG. J Nucl Med 2000, 41:71-77.
8. Kosaka K. Diffuse Lewy body disease. Intern Med 1998, 37:1-10.
9. Gibb W.R., Lees A.J. The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease. Neuropathol Appl Neurobiol 1989, 15:27-44.
10. Uchiyama M., Isse K., Tanaka K., Yokota N., Hamamoto M., Aida S., et al. Incidental Lewy body disease in a patient with REM sleep behavior disorder. Neurology 1995, 45:709-712.
11. Braak H., Ghebremedhin E., Rüb U., Bratzke H., Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 2004, 318:121-134.
12. Braak H., de Vos R.A., Bohl J., Del Tredici K. Gastric alpha-synuclein immunoreaction inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett 2006, 396:67-72.
13. Orimo S., Amino T., Itoh Y., Takahashi A., Kojo T., Uchihara T., et al. Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease. Acta Neuropathol (Burl) 2005, 109:583-588.
14. Boeve B.F., Silber H.M., Saper C.B., Ferman T.J., Dickson D.W., Parisi J.E., et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 2007, 130:2770-2788.
15. Lai Y.Y., Siegel J.M. Physiological and anatomical link between Parkinson-like disease and REM sleep behavior disorder. Mol Neurobiol 2003, 27:137-151.
16. 123I-MIBG scintigraphy in patients with essential tremor. Mov Disord 2006, 21:1235-1238.
17. 123I] metaiodobenzylguanidine scintigraphy for vascular Parkinsonism. Mov Disord 2006, 21:1990-1994.
18. American Academy of Sleep Medicine Rapid eye movement sleep behavior disorder. The international classification of sleep disorders; diagnostic and coding manual 2005, 148-151. American Academy of Sleep Medicine, Westchester. 2nd ed.
19. 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies. J Nucl Med 2006, 47:1099-1101.
20. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. Neurology 1996, 46:1470-1472.
21. Gagnon J.F., Postuma R.B., Mazza S., Doyon J., Montplaisir J. Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases. Lancet Neurol 2006, 5:424-432.
22. 123I-MIBG cardiac scintigraphy provides clues to the underlying neurodegenerative disorder in idiopathic REM sleep behavior disorder. Sleep 2008, 31:717-723.
23. Orimo S., Kanazawa T., Nakamura A., Uchihara T., Mori F., Kakita A., et al. Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy. Acta Neuropathol 2007, 113:81-86.
24. 123I-MIBG scintigraphy in patients with PSP, CBD, and MSA. J Neurol 2006, 253(suppl. 3):iii35-iii40.
25. Scaglione C., Vignatelli L., Plazzi G., Marchese R., Negrotti A., Rizzo G., et al. REM sleep behaviour disorder in Parkinson's disease: a questionnaire-based study. Neurol Sci 2005, 25:316-321.
26. Olson E.J., Boeve B.F., Silber M.H. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain 2000, 123:331-339.
27. Orimo S., Amino T., Yokochi M., Kojo T., Uchihara T., Takahashi A., et al. Preserved cardiac sympathetic nerve accounts for normal cardiac uptake of MIBG in PARK2. Mov Disord 2005, 20:1350-1353.
28. 123I-metaiodobenzylguanidine uptake in genetic Parkinson's disease. Mov Disord 2008, 23:21-27.
29. Zaccai J., Brayne C., McKeith I., Matthews F., Ince P. MRC cognitive function, ageing neuropathology study. Patterns and stages of alpha-synucleinopathy: relevance in a population-based cohort. Neurology 2008, 70:1042-1048.